Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Celebrating a £5million British Heart Foundation renewal award to the University of Oxford to advance cardiovascular science.

Picture of the BHF Centre staff members in the building

The new BHF Oxford Centre of Research Excellence (BHF Oxford CRE) has launched today at the University of Oxford. Building on three previous Centre awards since 2008, the BHF Oxford CRE unites the University’s cross-disciplinary cardiovascular research community. From discovery science through to clinical and population health research, the BHF Oxford CRE will continue to advance cardiovascular sciences and benefit for patients.

Professor Keith Channon, Director of the BHF Oxford CRE said “We are delighted to receive this renewed support from the BHF to continue the excellent research that is being done by our strong and diverse network of researchers in Oxford. With teams spanning across multiple disciplines we can address new targeted and critical areas of research for the cardiovascular sciences - with the overall goal of translating discoveries from the laboratory through to clinical practice. Through our early- to mid-career development and training opportunities we are continuing to promote a diverse and inclusive research culture allowing our researchers to compete at the highest level and nurture them to become future cardiovascular research leaders.”

With the new round of funding, the BHF Oxford CRE has three key research themes in areas where it sees clear potential to deliver world leading advances:

Led by Professor Cornelia van Duijn and co-led by Professor Blanca Rodriguez, the Big Data & Computational Science theme builds on the Centre’s capabilities in data analysis for population cardiovascular health, including a new focus on vascular dementia. We are working in collaboration between cardiologists, engineers and computer scientists to extend upon big data techniques, artificial intelligence, modelling and simulation which will provide new insights into treatments for cardiovascular disease.

 

Read the full story on the Radcliffe Department of Medicine website.

Similar stories

First clinical study in GSK-Oxford Experimental Medicine Collaboration starts as first patient dosed in ulcerative colitis experimental trial

The first patient in the PEGASUS clinical study, part of the GSK-University of Oxford Experimental Medicine Collaboration, received the first dose last week, on 8 October 2026.

Wearable chest patch could support hospital-level care at home, study finds

Researchers in Oxford have shown that wearable chest patches can be used to effectively monitor vital signs in many acutely unwell patients receiving hospital-level care in their own homes.

Brain immune cells protect neurons in Parkinson’s disease by “nibbling” harmful material

New research, published in Science Translational Medicine, reveals how a specialised population of the brain’s immune cells can remove harmful protein clumps from nerve cells (neurons), pointing to potential new treatments for Parkinson’s disease.

Phase I clinical study of ChAdOx1 BDBV vaccine launches in Uganda

The Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM Uganda Research Unit) has launched a Phase I clinical study evaluating the safety and immunogenicity of a candidate vaccine against Bundibugyo virus disease (BVD), a severe form of Ebola virus disease caused by Bundibugyo virus (BDBV), in partnership with the University of Oxford.

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.